Abstract
Sepsis-induced lung injury is one of the severest complications in sepsis. ItĀ belongs to the category of acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). On the basis of both experimental and clinical studies, the pathogenesis of sepsis-induced lung injury includes the contributions of inflammatory response, vascular hyperpermeability, alveolar edema accumulation, and ventilator-induced lung injury. Survival has been increased with the strategy of protective ventilation based on a ventilator. However, specific effective pharmacologic therapies are still lacking, in spite of the tests of some anti-inflammatory and anticoagulant agents. As new therapeutic strategies, cell therapy and gene therapy are still in their infancy, and their potentials remain to be evaluated. Although a number of basic studies show that some traditional Chinese medicines can protect against ALI or ARDS, it still needs to be further verified by clinical trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801ā10.
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2(7511):319ā23.
Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3):818ā24.
Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526ā33.
Riviello ED, Kiviri W, Twagirumugabe T, et al. Hospital incidence and outcomes of ARDS using the Kigali modification of the Berlin definition. Am J Respir Crit Care Med. 2016;193(1):52ā9.
Calfee CS, Janz DR, Bernard GR, et al. Distinct molecular phenotypes of direct versus indirect ARDS in single and multicenter studies. Chest. 2015;147(6):1539ā48.
Tejera P, Meyer NJ, Chen F, et al. Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. J Med Genet. 2012;49(11):671ā80.
Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time: a systematic review. Am J Respir Crit Care Med. 2009;179(3):220ā7.
Vincent JL, Abraham E. The last 100 years of sepsis. Am J Respir Crit Care Med. 2006;173(3):256ā63.
Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, et al. Experimental models of sepsis and their clinical relevance. Shock. 2008;30(1):53ā9.
Parker SJ, Watkins PE. Experimental models of gram-negative sepsis. Br J Surg. 2001;88(1):22ā30.
Wittekindt OH. Tight junctions in pulmonary epithelia during lung inflammation. Pflugers Arch. 2017;469(1):135ā47.
Henderson RB, Hobbs JAR, Mathies M, et al. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood. 2003;102(1):328ā35.
Li L, Zhang H, Min D, et al. Sox9 activation is essential for the recovery of lung function after acute lung injury. Cell Physiol Biochem. 2015;37(3):1113ā22.
Leung WS, Yang ML, Lee SS, et al. Protective effect of zerumbone reduces lipopolysaccharide-induced acute lung injury via antioxidative enzymes and Nrf2/HO-1 pathway. Int Immunopharmacol. 2017;46:194ā200.
Blondonnet R, Constantin JM, Sapin V, et al. A pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers. 2016;2016(21):1ā20.
Horowitz JC, Cui Z, Moore TA, et al. Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2006;290:415ā25.
Hu R, Cheng Y, Jing H, Wu H, et al. Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K/Akt pathway. Shock. 2014;42(4):327ā36.
Hu Y, Lou J, Mao YY, et al. Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury. Autophagy. 2016;12(12):2286ā99.
Gunther A, Mosavi P, Heinemann S. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000;161:454ā62.
Day YJ, Chen KH, Chen YL, et al. Preactivated and disaggregated shape-changed platelets protected against acute respiratory distress syndrome complicated by sepsis through inflammation suppression. Shock. 2016;46(5):575ā86.
Robert SM, Zhu H, Constantin G, et al. Complement inhibition decreases early fibrogenic events in the lung of septic baboons. J Cell Mol Med. 2015;19(11):2549ā63.
Cross LJM, Matthay MA. Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury. Crit Care Clin. 2011;27(2):355ā77.
Dowdy DW, Eid MP, Dennison CR, et al. Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med. 2006;32(8):1115ā24.
Corada M, Mariotti M, Thurston G, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci. 1999;96:9815ā20.
Wessel F, Winderlich M, Holm M, et al. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol. 2014;15:223ā30.
Schulte D, Kuppers V, Dartsch N, et al. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 2011;30:4157ā70.
Sidibe A, Imhof BA. VE-cadherin phosphorylation decides: vascular permeability or diapedesis. Nat Immunol. 2014;15:215ā7.
Broermann A, Winderlich M, Block H, et al. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF induced vascular permeability in vivo. J Exp Med. 2011;208:2393ā401.
Camerer E, Regard JB, Cornelissen I, et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest. 2009;119:1871ā9.
Zhang J, Yang G, Zhu Y, et al. Relationship of Cx43 regulation of vascular permeability to osteopontin-tight junction protein pathway after sepsis in rats. Am J Physiol Regul Integr Comp Physiol. 2017;443:R1.
Dong R, Hu D, Yang Y, et al. EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway. Oncotarget. 2017;8(31):50958ā71.
Peters DM, Vadasz I, Wujak L, et al. TGF-Ī² directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury. Proc Natl Acad Sci U S A. 2014;111:E374ā83.
Roux J, McNicholas CM, Carles M, et al. IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K dependent mechanism. FASEB J. 2013;27:1095ā106.
Cui Y, Ding Y, Chen L, et al. Dexmedetomidine enhances human lung fluid clearance through improving alveolar sodium transport. Fundam Clin Pharmacol. 2017;31(4):429ā37.
Frank JA, Pittet JF, Lee H, et al. High tidal volume ventilation induces NOS2 and impairs cAMP- dependent air space fluid clearance. Am J Physiol Lung Cell Mol Physiol. 2003;284:L791ā8.
Eckle T, Grenz A, Laucher S, et al. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest. 2008;118:3301ā15.
Vadasz I, Sznajder J. Gas exchange disturbances regulate alveolar fluid clearance during acute lung injury. Front Cell Infect Microbiol. 2017;8:757ā64.
Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235ā49.
Mazzocchi LC, Vohwinkel CU, Mayer K, et al. TGF-Ī² inhibits alveolar protein transport by promoting shedding, regulated intramembrane proteolysis and transcriptional downregulation of megalin. Am J Physiol Lung Cell Mol Physiol. 2017;313(5):L807ā24.
Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875ā9.
Matthay MA. Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med. 2014;189(11):1301ā8.
Fanelli V, Mascia L, Puntorieri V, et al. Pulmonary atelectasis during low stretch ventilation: āopen lungā versus ālung restā strategy. Crit Care Med. 2009;37:1046ā53.
Dolinay T, Himes B, Shumyatcher M, et al. Integrated stress response mediates epithelial injury in mechanical ventilation. Am J Respir Cell Mol Biol. 2017;57(2):193ā203.
Imai Y, Parodo J, Kajikawa O, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA. 2003;289:2104ā12.
Arndt U, Wennemuth G, Barth P, et al. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol. 2002;76:9298ā306.
Chimenti L, CamprubĆ-Rimblas M, Guillamat-Prats R, et al. Nebulized heparin attenuates pulmonary coagulopathy and inflammation through alveolar macrophages in a rat model of acute lung injury. Thromb Haemost. 2017;117(11):2125ā34.
Bosmann M, Ward PA. Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis. Adv Exp Med Biol. 2012;946:147ā59.
Katz JN, Kolappa KP, Becker RC. Beyond thrombosis: the versatile platelet in critical illness. Chest. 2011;139(3):658ā68.
Williams AE, Chambers RC. The mercurial nature of neutrophils: still an enigma in ARDS? Am J Physiol Lung Cell Mol Physiol. 2014;306(3):L217ā30.
Rubenfeld GD. Confronting the frustrations of negative clinical trials in acute respiratory distress syndrome. Ann Am Thorac Soc. 2015;12(1):S58ā63.
McDonald B, Urrutia R, Yipp BG, et al. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe. 2012;12(3):324ā33.
Leissinger M, Kulkarni R, Zemans RL, et al. Investigating the role of nucleotide-binding oligomerization domain-like receptors in bacterial lung infection. Am J Respir Crit Care Med. 2014;189(12):1461ā8.
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11(5):373ā84.
Ray NB, Durairaj L, Chen BB, et al. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat Med. 2010;16(10):1120ā7.
Qi D, Wang D, Zhang C, et al. Vaspin protects against LPS-induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK-3Ī² pathway. Int J Mol Med. 2017;40:1803ā17.
Simmons JD, Lee YL, Mulekar S, et al. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg. 2013;258(4):591ā6.
Chen S, Zuo X, Yang M, et al. Severe multiple organ injury in HSF1 knockout mice induced by lipopolysaccharide is associated with an increase in neutrophil infiltration and surface expression of adhesion molecules. J Leukoc Biol. 2012;92(4):851ā7.
Vieillard-Baron A, Matthay M, Teboul JL, et al. Expertsā opinion on management of hemodynamics in ARDS patients: focus on the effects of mechanical ventilation. Intensive Care Med. 2016;42(5):739ā49.
Chiumello D, Brochard L, Marini JJ, et al. Respiratory support in patients with acute respiratory distress syndrome: an expert opinion. Crit Care. 2017;21(1):240ā8.
Lista G, Castoldi F, Fontana P, et al. Lung inflammation in preterm infants with respiratory distress syndrome: effects of ventilation with different tidal volumes. Pediatr Pulmonol. 2006;41(4):357ā63.
Sahetya SK, Mancebo J, Brower RG. 50 years of research in ARDS. Tidal volume selection in the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;08:1629ā50.
Frank JA, Parsons PE, Matthay MA. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest. 2006;130(6):1906ā14.
Goligher EC, Kavanagh BP, Rubenfeld GD, et al. Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med. 2014;190(1):70ā6.
Ogura H, Gando S, Iba T, et al. SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia. Shock. 2007;28(4):411ā7.
Dixon B, Schultz MJ, Smith R, et al. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care. 2010;14:180.
Erlich JM, Talmor DS, Cartin-Ceba R, et al. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study. Chest. 2011;139:289ā95.
Hess R, Wujak L, Hesse C, et al. Coagulation factor XII regulates inflammatory responses in human lungs. Thromb Haemost. 2017;10:1896ā907.
Igonin AA, Protsenko DN, Galstyan GM, et al. C1-esterase inhibitor infusion increases survival rates for patients with sepsis. Crit Care Med. 2012;40:770ā7.
Tomoharu M, Ali KA, Shinichi N, et al. A three-phase approach for the early identification of acute lung injury induced by severe sepsis. In Vivo. 2016;30:341ā50.
Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med. 2016;140(4):345ā50.
Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369:1553ā65.
Hooper RG, Kearl RA. Established ARDS treated with a sustained course of adrenocorticosteroids. Chest. 1990;97:138ā43.
Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671ā84.
Iwata K, Doi A, Ohji G, et al. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern Med. 2010;49:2423ā32.
Orihara K, Matsuda A. Pathophysiological roles of microvascular alterations in pulmonary inflammatory diseases: possible implications of tumor necrosis factor-alpha and CXC chemokines. Int J Chron Obstruct Pulmon Dis. 2008;3(4):619ā27.
Takano Y, Mitsuhashi H, Ueno K. Alpha, 25-Dihydroxy vitamin D(3) inhibits neutrophil recruitment in hamster model of acute lung injury. Steroids. 2011;76:1305ā9.
Parekh D, Dancer RC, Lax S, et al. Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial. Trials. 2013;14:100.
Sadowitzaa B, Royaa S, Gattobb LA. Lung injury induced by sepsis: lessons learned from large animal models and future directions for treatment. Expert Rev Anti Infect Ther. 2011;9(12):1169ā78.
Bein T, Grasso S, Moerer O, et al. The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia. Intensive Care Med. 2016;42(5):699ā711.
Esteban A, Anzueto A, Frutos F, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28 day international study. JAMA. 2002;287:345ā55.
Frank JA, Gutierrez JA, Jones KD, et al. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med. 2002;165:242ā9.
Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33:1ā6.
Pepe PE, Hudson LD, Carrico JC. Early application of positive end-expiratory pressure in patients at risk of adult respiratory distress syndrome. N Engl J Med. 1984;311:281ā6.
Crotti S, Mascheroni D, Caironi P, et al. Recruitment and derecruitment during acute respiratory failure: a clinical study. Am J Respir Crit Care Med. 2001;164:131ā40.
Daoud EG, Farag HL, Chatburn RL, et al. Airway pressure release ventilation: what do we know? Respir Care. 2012;57(2):282ā92.
Marcelo BP, Amato MD, Maureen O, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747ā55.
Guerin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159ā68.
Cressoni M, Chiumello D, Algieri I, et al. Opening pressures and atelectrauma in acute respiratory distress syndrome. Intensive Care Med. 2017;43(5):603ā11.
Sklar MC, Fan E, Goligher EC. High-frequency oscillatory ventilation in adults with ards: past, present, and future. Chest. 2017;3(17):31185ā6.
Umbrello M, Marino A, Chiumello D. Tidal volume in acute respiratory distress syndrome: how best to select it. Ann Transl Med. 2017;5(14):287.
Del Sorbo L, Cypel M, Fan E, et al. Extracorporeal life support for adults with severe acute respiratory failure. Lancet Respir Med. 2014;2(2):154ā64.
Abrams D, Brodie D. Extracorporeal membrane oxygenation forāadult respiratory failure: 2017 update. Chest. 2017;152(3):639ā49.
Vaquer S, de Haro C, Peruga P, et al. Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome. Ann Intensive Care. 2017;7(1):51ā64.
Leligdowicz A, Fan E. Extracorporeal life support for severe acute respiratory distress syndrome. Curr Opin Crit Care. 2015;21(1):13ā9.
Combes A, Pesenti A, Ranieri VM. Fifty years of research in ARDS. Is extracorporeal circulation the future of acute respiratory distress syndrome management. Am J Respir Crit Care Med. 2017;195(9):1161ā70.
Ragaller M, Bleyl JU, Koch T, et al. From isoflurane to perfluorohexane? Perfluorocarbons--therapeutic strategies in acute lung failure. Anaesthesist. 2000;49(4):291ā301.
Levy SD, Alladina JW, Hibbert KA, et al. High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet. 2016;387(10030):1867ā78.
Beitler JR, Goligher EC, Schmidt M, et al. Personalized medicine for ARDS: the 2035 research agenda. Intensive Care Med. 2016;42(5):756ā67.
Hashimoto S, Sanui M, Egi M, et al. The clinical practice guideline for the management of ARDS in Japan. J Intensive Care. 2017;5:50ā82.
Wang L, Bastarache JA, Wickersham N, et al. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol. 2007;36:497ā503.
Robriquet L, Collet F, Tournoys A, et al. Intravenous administration of activated protein C in pseudomonas induced lung injury: impact on lung fluid balance and the inflammatory response. Respir Res. 2006;7:41.
Healy LD, Puy C, FernĆ”ndez JA, et al. Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo. J Biol Chem. 2017;292(21):8616ā29.
Cornet AD, Groeneveld AB, Hofstra JJ, et al. Recombinant human activated protein C in the treatment of acute respiratory distress syndrome: a randomized clinical trial. PLoS One. 2014;9(3):90983ā94.
Christiaans SC, Wagener BM, Esmon CT, et al. Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol. 2013;305(7):L455ā66.
Ma J, Bai J. Protective effects of heparin on endothelial cells in sepsis. Int J Clin Exp Med. 2015;8(4):5547ā52.
Horie S, Masterson C, Devaney J, et al. Stem cell therapy for acute respiratory distress syndrome: a promising future. Curr Opin Crit Care. 2016;22(1):14ā20.
Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18:759ā65.
Johnson CL, Soeder Y, Dahlke MH. Concise review: mesenchymal stromal cell-based approaches for the treatment of acute respiratory distress and sepsis syndromes. Stem Cells Transl Med. 2017;6(4):1141ā51.
Matthay MA, Goolaerts A, Howard JP, et al. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit Care Med. 2010;38(10):569ā73.
Lee JW, Krasnodembskaya A, McKenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med. 2013;187:751ā60.
Keane C, Jerkic M, Laffey JG. Stem cell-based therapies for sepsis. Anesthesiology. 2017;127(6):1017ā34.
HorĆ”k J, Nalos L, MartĆnkovĆ” V, et al. Mesenchymal stem cells in sepsis and associated organ dysfunction: a promising future or blind alley? Stem Cells Int. 2017;2017:1ā10.
Zheng G, Huang L, Tong H, et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res. 2014;15:39.
Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3:24ā32.
Liu KD, Wilson JG, Zhuo H, et al. Design and implementation of the START (STem cells for ARDS treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Ann Intensive Care. 2014;4:22.
Zhou J, Wu Y, Henderson F, et al. Adenoviral gene transfer of a mutant surfactant enzyme ameliorates pseudomonas-induced lung injury. Gene Ther. 2006;13:974ā85.
Reiss LK, Schuppert A, Uhlig S. Inflammatory processes during acute respiratory distress syndrome: a complex system. Curr Opin Crit Care. 2017;23:1ā9.
Huang Y, Sauthoff H, Herscovici P, et al. Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med. 2008;36:262ā7.
Bromberg Z, Raj N, Goloubinoff P, et al. Enhanced expression of 70-kilodalton heat shock protein limits cell division in a sepsis-induced model of acute respiratory distress syndrome. Crit Care Med. 2008;36:246ā55.
Li Y, Dong J, Wu M. Human Apo A-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol. 2008;590:417ā22.
Shu Q, Shi Z, Zhao Z, et al. Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of Ī²-defensin-2 in rats. Shock. 2006;26:365ā71.
Han J, Lu X, Zou L, et al. E-prostanoid 2 receptor overexpression promoted mesenchymal stem cell attenuated lung injury. Hum Gene Ther. 2016;27:1ā10.
Mei SH, Dos Santos CC, Stewart DJ. Advances in stem cell and cell-based gene therapy approaches for experimental acute lung injury: a review of preclinical studies. Hum Gene Ther. 2016;27(10):802ā12.
Chen G, Xu Y, Jing J, et al. The anti-sepsis activity of the components of Huanglian Jiedu Decoction with high lipid A-binding affinity. Int Immunopharmacol. 2017;46:87ā96.
Ding XM, Pan L, Wang Y, et al. Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1- CX3CR1 axis and NF-ĪŗB pathway in CX3CL1-knockout mice. Int J Mol Med. 2016;37(3):703ā15.
Huang K-L, Chen C-S, Hsu C-W, Li M-H, Chang H, Tsai S-H, Chu S-J. Therapeutic effects of baicalin on lipopolysaccharide-induced acute lung injury in rats. Am J Chin Med. 2008;36(02):301ā11.
Gu XH, Xu LJ, Liu ZQ, et al. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimerās disease. Behav Brain Res. 2016;311:309ā21.
Tsai CL, Lin YC, Wang HM, et al. Baicalein, an active component of scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats. J Ethnopharmacol. 2014;153(1):197ā206.
Wang L, Chen J, Wang B, et al. Protective effect of quercetin on lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammatory cell influx. Exp Biol Med. 2014;239(12):1653ā62.
Takashima K, Matsushima M, Hashimoto K, et al. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury. Respir Res. 2014;15(1):150ā60.
Huang R, Zhong T, Wu H. Experimental research Quercetin protects against lipopolysaccharide-induced acute lung injury in rats through suppression of inflammation and oxidative stress. Arch Med Sci. 2015;11(2):427ā32.
Kumari A, Tyagi N, Dash D, et al. Intranasal curcumin ameliorates lipopolysaccharide-induced acute lung injury in mice. Inflammation. 2015;38(3):1103ā12.
Xin W, Zhang L, Fan H, et al. Escin attenuates acute lung injury induced by endotoxin in mice. Eur J Pharm Sci. 2011;42(1ā2):73ā80.
Qiu J, Yu L, Zhang X, et al. Asiaticoside attenuates lipopolysaccharide-induced acute lung injury via down-regulation of NF-ĪŗB signaling pathway. Int Immunopharmacol. 2015;26(1):181ā7.
Guan S, Xiong Y, Song B, et al. Protective effects of salidroside from Rhodiola rosea on LPS-induced acute lung injury in mice. Immunopharmacol Immunotoxicol. 2012;34(4):667ā72.
Lu R, Wu Y, Guo G, et al. Salidroside protects lipopolysaccharide-induced acute lung injury in mice. Dose Response. 2016;14(4):1ā5.
Li MH, Kothandan G, Cho SJ, et al. Magnolol inhibits LPS-induced NF-Īŗ B/Rel activation by blocking p38 kinase in murine macrophages. Korean J Physiol Pharmacol. 2010;14(6):353ā8.
Fu Y, Liu B, Feng X, et al. The effect of magnolol on the toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice. Eur J Pharmacol. 2012;689(1):255ā61.
Zhou H, Bian D, Jiao X, et al. Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability. Inflamm Res. 2011;60(10):981ā90.
Cao Q, Jing C, Tang X, et al. Protective effect of resveratrol on acute lung injury induced by lipopolysaccharide in mice. Anat Rec. 2011;294(3):527ā32.
Li T, Zhang J, Feng J, et al. Resveratrol reduces acute lung injury in a LPS induced sepsis mouse model via activation of Sirt1. Mol Med Rep. 2013;7(6):1889ā95.
Zhang Z, Chen N, Liu JB, et al. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88 dependent Toll-like receptor 4 signaling pathway. Mol Med Rep. 2014;10(1):101ā6.
Bae HB, Li M, Kim JP, et al. The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model. Inflammation. 2010;33(2):82ā91.
Liu W, Dong M, Bo L, Li C, Liu Q, Li Y, Ma L, Xie Y, Fu E, Mu D, Pan L, Jin F, Li Z. Epigallocatechin-3-gallate ameliorates seawater aspiration-induced acute lung injury via regulating inflammatory cytokines and inhibiting JAK/STAT1 pathway in rats. Mediators Inflamm. 2014;2014:1ā12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Xiao, G., Xiao, X. (2019). Sepsis-Induced Lung Injury: The Mechanism and Treatment. In: Fu, X., Liu, L. (eds) Severe Trauma and Sepsis. Springer, Singapore. https://doi.org/10.1007/978-981-13-3353-8_15
Download citation
DOI: https://doi.org/10.1007/978-981-13-3353-8_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3352-1
Online ISBN: 978-981-13-3353-8
eBook Packages: MedicineMedicine (R0)